TB skin test for patients with rheumatologic conditions
Part of Infections clinical trials.
This trial is testing a new type of skin test (called ESAT6/CFP10) to check for TB infection in people who have a rheumatologic disease and are about to start certain medications (b/tsDMARDs). The goal is to see if this skin test works well for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with at least one rheumatologic disease (like rheumatoid arthritis, lupus, or other similar conditions).
- You are planning to start a type of medication called b/tsDMARDs (biologic or targeted synthetic disease-modifying antirheumatic drugs).
- You can communicate in English or Chinese.
- You do not have active tuberculosis (TB) and you are not currently being treated for TB or a latent TB infection.
- You do not have a serious mental illness that would prevent you from participating.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to find hidden (subclinical) tuberculosis (TB) in people with serious kidney disease or those who have had a kidney transplant. If you have kidney failure on dialysis or have a kidney transplant, you may qualify and help improve TB detection.
This trial checks if a blood test can find TB DNA before a lung procedure called bronchoscopy. It may help people who need a bronchoscopy but cannot cough up sputum for testing.
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This study is tracking how many people with autoimmune rheumatic diseases develop tuberculosis. By joining, you help doctors understand the risk better.
Hear when a new Tuberculosis (TB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.